These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34157202)

  • 1. Application of a dual mechanistic approach to support bilastine dose selection for older adults.
    Kim C; Lo Re V; Rodriguez M; Lukas JC; Leal N; Campo C; García-Bea A; Suarez E; Schmidt S; Vozmediano V
    CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1006-1017. PubMed ID: 34157202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design.
    Vozmediano V; Sologuren A; Lukas JC; Leal N; Rodriguez M
    Pharm Res; 2017 Dec; 34(12):2720-2734. PubMed ID: 28971281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine.
    Jauregizar N; de la Fuente L; Lucero ML; Sologuren A; Leal N; Rodríguez M
    Clin Pharmacokinet; 2009; 48(8):543-54. PubMed ID: 19705924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population.
    Vozmediano V; Lukas JC; Encinas E; Schmidt S; Sologuren A; Valiente R; Labeaga L; Campo C; Rodriguez M
    Eur J Pharm Sci; 2019 Feb; 128():180-192. PubMed ID: 30468868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of preclinical and clinical knowledge to predict intravenous PK in human: bilastine case study.
    Vozmediano V; Ortega I; Lukas JC; Gonzalo A; Rodriguez M; Lucero ML
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):33-41. PubMed ID: 23619917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the single-dose pharmacokinetics of bilastine in subjects with various degrees of renal insufficiency.
    Lasseter KC; Sologuren A; La Noce A; Dilzer SC
    Clin Drug Investig; 2013 Sep; 33(9):665-73. PubMed ID: 23873362
    [TBL] [